Moderna (MRNA)
(Delayed Data from NSDQ)
$108.85 USD
+0.96 (0.89%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $108.87 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Income Statements
Fiscal Year end for Moderna, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 6,848 | 19,263 | 18,471 | 803 | 60 |
Cost Of Goods | 4,693 | 5,416 | 2,617 | 8 | 0 |
Gross Profit | 2,155 | 13,847 | 15,854 | 795 | 60 |
Selling & Adminstrative & Depr. & Amort Expenses | 6,394 | 4,427 | 2,558 | 1,559 | 606 |
Income After Depreciation & Amortization | -4,239 | 9,420 | 13,296 | -763 | -546 |
Non-Operating Income | 297 | 155 | -11 | 19 | 31 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -3,942 | 9,575 | 13,285 | -745 | -515 |
Income Taxes | 772 | 1,213 | 1,083 | 3 | -1 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -4,714 | 8,362 | 12,202 | -747 | -514 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -4,714 | 8,362 | 12,202 | -747 | -514 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -3,679 | 9,799 | 13,582 | -722 | -518 |
Depreciation & Amortization (Cash Flow) | 560 | 379 | 286 | 41 | 27 |
Income After Depreciation & Amortization | -4,239 | 9,420 | 13,296 | -763 | -546 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 382.00 | 416.00 | 431.00 | 381.33 | 330.80 |
Diluted EPS Before Non-Recurring Items | -12.33 | 20.12 | 28.29 | -1.96 | -1.55 |
Diluted Net EPS (GAAP) | -12.33 | 20.12 | 28.29 | -1.96 | -1.55 |
Fiscal Year end for Moderna, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 2,811.00 | 1,831.00 | 344.00 | 1,862.00 |
Cost Of Goods | NA | 929.00 | 2,241.00 | 731.00 | 792.00 |
Gross Profit | NA | 1,882.00 | -410.00 | -387.00 | 1,070.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1,876.00 | 1,602.00 | 1,480.00 | 1,436.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 6.00 | -2,012.00 | -1,867.00 | -366.00 |
Non-Operating Income | NA | 64.00 | 54.00 | 118.00 | 61.00 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 70.00 | -1,958.00 | -1,749.00 | -305.00 |
Income Taxes | NA | -147.00 | 1,672.00 | -369.00 | -384.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 217.00 | -3,630.00 | -1,380.00 | 79.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 217.00 | -3,630.00 | -1,380.00 | 79.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 395.00 | 381.00 | 381.00 | 405.00 |
Diluted EPS Before Non-Recurring Items | NA | 0.55 | -1.39 | -3.62 | 0.19 |
Diluted Net EPS (GAAP) | NA | 0.63 | -9.53 | -3.62 | 0.19 |